At a glance
ClinicalIndex Comparison RecordN/ACompleted· 5 enrolled
Drug / intervention
UV Light Treatmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Respiratory Application of a Novel Ultraviolet Light Delivery Device for Patients Infected With COVID-19: A Pilot Study
In Brief
A clinical study evaluating UV Light Treatment for Coronavirus. Completed, enrolled 5 participants across 1 site.
Detailed Summary
This pilot study will assess the safety and effectiveness of UV light treatment in hospitalized patients with COVID-19.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronavirus
CountriesUnited States
CollaboratorsAytu BioPharma, Inc.
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedOct 2020
Enrollment StartOct 2020
Primary CompletionDec 2020
TodayJul 2026
First PostedOct 1, 2020
Enrollment StartOct 30, 2020
Primary CompletionDec 28, 2020
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5.8 years ago
Interventions
UV Light Treatmentdevice
UV light therapy administered while patient is mechanically ventilated